Biblio
Export 1756 results:
Author Title Type [ Year] Filters: First Letter Of Last Name is L [Clear All Filters]
“Longitudinal Effects of Herpesviruses on Multiple Cognitive Outcomes in Healthy Elderly Adults.”, J Alzheimers Dis, vol. 94, no. 2, pp. 751-762, 2023.
, “Machine Learning Selection of Most Predictive Brain Proteins Suggests Role of Sugar Metabolism in Alzheimer's Disease.”, J Alzheimers Dis, vol. 92, no. 2, pp. 411-424, 2023.
, “Machine Learning Selection of Most Predictive Brain Proteins Suggests Role of Sugar Metabolism in Alzheimer's Disease.”, J Alzheimers Dis, vol. 92, no. 2, pp. 411-424, 2023.
, “Mediation Effect of Brain Volume on the Relationship Between Peripheral Inflammation and Cognitive Decline.”, J Alzheimers Dis, vol. 95, no. 2, pp. 523-533, 2023.
, “Microglia-Mediated Neurovascular Unit Dysfunction in Alzheimer's Disease.”, J Alzheimers Dis, vol. 94, no. s1, pp. S335-S354, 2023.
, “Microglia-Mediated Neurovascular Unit Dysfunction in Alzheimer's Disease.”, J Alzheimers Dis, vol. 94, no. s1, pp. S335-S354, 2023.
, “Midlife Neuropsychological Profiles and Associated Vascular Risk: The Bogalusa Heart Study.”, J Alzheimers Dis, vol. 94, no. 1, pp. 101-113, 2023.
, “Mindfulness Prevents Depression and Psychopathology in Elderly People with Mild to Moderate Alzheimer's Disease: A Randomized Clinical Trial.”, J Alzheimers Dis, vol. 91, no. 1, pp. 471-481, 2023.
, “Montreal Cognitive Assessment in Mild Cognitive Impairment: Relationship with Cerebrospinal Fluid Biomarkers and Conversion to Dementia.”, J Alzheimers Dis, vol. 96, no. 3, pp. 1173-1182, 2023.
, “Moral Emotions and Their Brain Structural Correlates Across Neurodegenerative Disorders.”, J Alzheimers Dis, vol. 92, no. 1, pp. 153-169, 2023.
, “Multi-Site Cross-Site Inter-Rater and Test-Retest Reliability and Construct Validity of the MarkVCID White Matter Hyperintensity Growth and Regression Protocol.”, J Alzheimers Dis, vol. 96, no. 2, pp. 683-693, 2023.
, “Neural Stem Cells in the Treatment of Alzheimer's Disease: Current Status, Challenges, and Future Prospects.”, J Alzheimers Dis, vol. 94, no. s1, pp. S173-S186, 2023.
, “Neuroinflammation: A Common Pathway in Alzheimer's Disease and Epilepsy.”, J Alzheimers Dis, vol. 94, no. s1, pp. S253-S265, 2023.
, “Neuroprotective Mechanisms of Amylin Receptor Activation, Not Antagonism, in the APP/PS1 Mouse Model of Alzheimer's Disease.”, J Alzheimers Dis, vol. 91, no. 4, pp. 1495-1514, 2023.
, “Non-Pharmacological Interventions for Feeding and Eating Disorders in Persons with Dementia: Systematic Review and Evidence Summary.”, J Alzheimers Dis, vol. 94, no. 1, pp. 67-88, 2023.
, “Non-Pharmacological Interventions for Feeding and Eating Disorders in Persons with Dementia: Systematic Review and Evidence Summary.”, J Alzheimers Dis, vol. 94, no. 1, pp. 67-88, 2023.
, “Non-Pharmacological Interventions for Feeding and Eating Disorders in Persons with Dementia: Systematic Review and Evidence Summary.”, J Alzheimers Dis, vol. 94, no. 1, pp. 67-88, 2023.
, “A Novel Strategy for Alzheimer's Disease Based on the Regulatory Effect of Amyloid-β on Gut Flora.”, J Alzheimers Dis, vol. 94, no. s1, pp. S227-S239, 2023.
, “A Novel Strategy for Alzheimer's Disease Based on the Regulatory Effect of Amyloid-β on Gut Flora.”, J Alzheimers Dis, vol. 94, no. s1, pp. S227-S239, 2023.
, “A Novel Strategy for Alzheimer's Disease Based on the Regulatory Effect of Amyloid-β on Gut Flora.”, J Alzheimers Dis, vol. 94, no. s1, pp. S227-S239, 2023.
, “Pathogenesis, Animal Models, and Drug Discovery of Alzheimer's Disease.”, J Alzheimers Dis, vol. 94, no. 4, pp. 1265-1301, 2023.
, “Physical Activity for Cognitive Health: A Model for Intervention Design for People Experiencing Cognitive Concerns and Symptoms of Depression or Anxiety.”, J Alzheimers Dis, vol. 94, no. 2, pp. 781-799, 2023.
, “Physical Activity for Cognitive Health: A Model for Intervention Design for People Experiencing Cognitive Concerns and Symptoms of Depression or Anxiety.”, J Alzheimers Dis, vol. 94, no. 2, pp. 781-799, 2023.
, “Plasma Amyloid-β Homeostasis Is Associated with Body Mass Index and Weight Loss in People with Overweight and Obesity.”, J Alzheimers Dis, vol. 93, no. 2, pp. 653-664, 2023.
, “Plasma Soluble ST2 Levels Are Higher in Neurodegenerative Disorders and Associated with Poorer Cognition.”, J Alzheimers Dis, vol. 92, no. 2, pp. 573-580, 2023.
,